Table 2 Clinical parameters of parenteral nutrition (PN) supplemented patients before and after PN supplementation. Patients allocated to group 1 received PN supplementation equivalent to 40% of the resting energy requirement (RER), while patients in group 2 received supplementation of 50% of the RER

 Mean ± SD

4.1 ± 2.1

3.5 ± 1.3

0.381

N/A

 Male

2 (18.2%)

4 (33.3%)

0.408

N/A

 Female

9 (81.8%)

8 (66.7%)

 Mean ± SD

0.38 ± 0.07

0.33 ± 0.07

0.158

0.37 ± 0.07

0.32 ± 0.06

0.102

0.37–0.55 L/L

 Mean ± SD

126.6 ± 25

110.3 ± 22.2

0.110

123 ± 25

105 ± 25

0.101

120–180 g/L

 Mean ± SD

5.3 ± 1.1

5.2 ± 1.2

0.892

5.4 ± 1.4

4.8 ± 1.1

0.244

5.5–8.5 X10¹²/L

 Median [IQR]

2.9 [1.9–8.1]

6.9 [2.6–9.1]

0.473

9.1 [6.8–14.1]

9.0 [4.8–12.4]

0.316

6.0–17.0 X10⁹/L

 Median [IQR]

1 [0.2–2.7]

4.4 [0.5–7.03]

0.185

4.0 [3–10.1]

5.4 [2.9–5.9]

0.761

3.0–11.5 X10⁹/L

 Median [IQR]

0 [0–0.1]

0.1 [0–0.6]

0.340

0 [0–0.15]

0.1 [0–0.35]

0.374

0.0–0.3 X10⁹/L

Lymphocytes

 Median [IQR]

1.9 [1.1–3.1]

1.3 [0.7–2.8]

0.309

2.3 [2–4.7]

2.9 [1.7–5.1]

0.517

1.0–4.8 X10⁹/L

 Median [IQR]

0.16 [0–0.6]

0.15 [0.0–0.3]

0.802

0.3 [0.1–1.0]

0.1 [0–0.575]

0.172

0.1–1.4 X10⁹/L

 Median [IQR]

0 [0–0.1]

0 [0–0]

0.208

0 [0–0]

0 [0–0]

0.506

0.0–0.9 X10⁹/L

 Median [IQR]

0 [0–0]

0 [0–0]

–

0 [0–0]

0 [0–0]

–

0.0 X10⁹/L

 Mean ± SD

325 ± 134.5

233.3 ± 139.9

0.140

313 ± 125

251 ± 113

0.241

200–600 X10⁹/L

 Median [IQR]

0 [0–0]

10 [4–21]

0.025

0 [0–0]

17 [4–28.5]

0.016

< 60 X10⁹/L

 Mean ± SD

51 ± 10.5

46.83 ± 11.8

0.382

45 ± 6.8

44 ± 7.1

0.808

N/A g/L

 Mean ± SD

6.2 ± 1.1

5.4 ± 1.2

0.085

5.9 ± 1.1

4.9 ± 1.1

0.038

4.11–7.94 mmol/L

 Median [IQR]

3 [2.1–4.8]

3.7 [2.48–8.15]

0.524

4.4 [2.5–8.6]

3.4 [2.9–4.9]

0.134

2.5–9.6 mmol/L

 Median [IQR]

38 [26–44]

42 [25–51]

0.735

49 [28–68]

49 [36–66]

0.771

44–159 μmol/L

 Median [IQR]

5.0 [4.4–8.5]

4.5 [3.4–5.6]

0.078

4.8 [4.3–6.8]

4.1 [3.5–4.5]

0.058

2.84–8.27 mmol/L

 Median [IQR]

2.0 [1–7]

3.0 [1–4.5]

0.369

3 [1–13]

2 [1–6.5]

0.251

0–15 μmol/L

 Median [IQR]

28 [19–40]

49 [31–81]

0.201

28 [20–44]

38 [14–72]

0.484

< 100 U/L

 Median [IQR]

19 [14–48]

28.5 [17.75–44]

0.487

21 [19–52]

33 [14–47]

0.535

< 43 U/L

 Median [IQR]

324 [174–651]

348 [173–649]

0.865

300 [201–532]

372 [130–585]

0.622

N/A U/L

 Median [IQR]

137 [129–145]

133 [125–140]

0.198

140 [129–143]

141 [137–144]

0.422

142–153 mmol/L

 Median [IQR]

101 [99–113]

104 [93–108]

0.459

107 [96–111]

108 [100–112]

0.545

110–118 mmol/L

 Mean ± SD

33.3 ± 5.0

28 ± 8.7

0.220

32.3 ± 4.2

26.1 ± 8.0

0.026

30–40 Units

 Median [IQR]

631[384–1774]

580 [315–1533]

0.587

700 [515–1175]

661 [515–1293]

0.603

< 1500 U/L

 Median [IQR]

287 [231–629]

233 [123–339]

0.200

306 [226–450]

326 [203–441]

0.752

< 250 U/L

 Median [IQR]

0.84 [0.6–1.13]

0.93 [0.49–1.2]

0.782

0.85 [0.6–1.14]

0.82 [0.65–1.13]

0.560

< 2.19 mmol/L

 Mean ± SD

45.6 ± 11

42.8 ± 10.1

0.521

43 ± 7.5

39 ± 7.6

0.222

52–82 g/L

 Mean ± SD

23.6 ± 5.9

22.3 ± 5.9

0.629

22 ± 4.3

20 ± 3.4

0.399

23–40 g/L

 Mean ± SD

22.3 ± 5.6

20.5 ± 6.3

0.487

21 ± 4.7

18 ± 6.1

0.220

25–45 g/L

 Mean ± SD

4.5 ± 0.6

4.2 ± 0.6

0.209

4.4 ± 0.43

4.4 ± 0.58

0.780

4.2–5.6 mmol/L

 Mean ± SD

278 ± 25

270 ± 19

0.463

278 ± 16

278 ± 13

1.00

280–330 mmol/L

 Mean ± SD

1.8 ± 0.45

1.8 ± 0.57

0.970

2.0 ± 0.39

1.9 ± 0.46

0.58

0.8–2.0 mmol/L

 Mean ± SD

2.2 ± 0.25

2.8 ± 0.6

0.04

2.17 ± 0.13

2.43 ± 0.29

0.05

2.20–2.70 mmol/L